Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,700

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

March 31, 2031

Study Completion Date

March 31, 2032

Conditions
AspirinGastric Cancer
Interventions
DRUG

Aspirin 100mg

Daily aspirin 100 mg for 5 years

DRUG

Placebo oral tablet

Daily placebo for 5 years

Trial Locations (10)

10408

RECRUITING

National Cancer Center, Goyang

21431

RECRUITING

Incheon St.Mary's Hospital/The Catholic University, Incheon

24253

RECRUITING

Hallym University Chuncheon Sacred Heart Hospital, Chuncheon

41404

RECRUITING

Kyungpook National University Chilgok Hospital, Daegu

49241

RECRUITING

Pusan National University Hospital, Busan

49267

RECRUITING

Kosin University Gospel Hospital, Busan

61469

RECRUITING

Chonnam National University Hospital, Gwangju

06973

RECRUITING

Chung-Ang University Hospital, Seoul

07061

RECRUITING

SMG-SNU Boramae Medical Center, Seoul

Unknown

NOT_YET_RECRUITING

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Incheon St.Mary's Hospital/The Catholic University

UNKNOWN

collaborator

Kosin University Gospel Hospital

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

SMG-SNU Boramae Medical Center

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

OTHER

collaborator

Chilgok Kyungpook National University

UNKNOWN

collaborator

Hallym University Medical Center

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

lead

National Cancer Center, Korea

OTHER_GOV